MDR1 polymorphism role in patients treated with cetuximab and irinotecan in irinotecan refractory colorectal cancer by Paule Bernard, Castagne Vincent, Picard Véronique, Saffroy Raphaël, Adam René, Guettier Catherine, Farinotti Robert, Bonhomme-Faivre Laurence in Medical oncology (Northwood, London, England) (2010).

[PMID: 19862647] PubMed


Discussed In Paper


Rx Annotations

No dosing information annotated.